Stocks to watch: RIL, Vedanta, Lupin, RITES, Aurobindo Pharma, and more

Here is a brief look at which stocks are likely to be in focus in today's trading.
Vedanta: Mining sector leader Vedanta Limited is set to convene a board of directors meeting on Monday, December 16, 2024. According to an exchange filing on December 11, the board will discuss the declaration of the fourth interim dividend for the financial year 2024-25. "The meeting of the Board of Directors ('Board') of the company is proposed to be held on Monday, December 16, 2024, to approve the fourth interim dividend on equity shares for the financial year 2024-25," the company said. If approved, the dividend issue date has been fixed as Tuesday, December 24, 2024.

Stocks to watch: RIL, Vedanta, Lupin, RITES, Aurobindo Pharma, and more


Reliance Industries: RIL has announced the acquisition of a 74 per cent stake in a Mumbai-based industrial estate developer for ₹16.28 billion (USD 192 million). The developer, Navi Mumbai IIA, was earlier known as Navi Mumbai Special Economic Zone (NMSEZ). The transition came after the Maharashtra state government approved its conversion into an integrated industrial zone in 2018. The remaining 26 per cent stake will be held by the Maharashtra City and Industrial Development Corporation (CIDCO).

Lupin: The pharma major has expanded its diabetes care portfolio by acquiring three anti-diabetes trademarks - GIBTULIO, GIBTULIO MET and AJADUO - from Boehringer Ingelheim. The acquisition is expected to strengthen the company's presence in the diabetes care market in India. Lupin aims to acquire full rights to these trademarks by March 2025.

RITES: Navratna company RITES Limited has received a Project Implementation Service Order from the Ministry of External Affairs for the construction of an integrated check post. The project worth ₹297.67 crore will enhance India’s border infrastructure. Reflecting RITES’ commitment to strengthening national infrastructure projects, the construction is scheduled to be completed in 59 months.

Aurobindo Pharma: Aurobindo Pharma has received an order from the Additional Commissioner (ST) of the Appellate Authority, Vijayawada, Andhra Pradesh, under the relevant provisions of the CGST Act, 2017 and the APGST Act, 2017, for the financial years 2017-18 (from July 2017) to 2019-20, directing it to pay GST of ₹5.68 crore through reverse charge of ITC, including interest of ₹4.80 crore.

Aeroflex Industries: Aeroflex Industries has announced its plans to raise up to ₹400 crore through Qualified Institutional Placement (QIP). The funds will be directed towards expansion plans and financial strengthening. Shareholders are scheduled to vote on the proposal during the Extraordinary General Meeting (EGM) to be held on January 15, 2025.

AFCONS Infrastructure: AFCONS Infrastructure has been awarded a significant contract by Madhya Pradesh Metro Rail Corporation for the Bhopal Metro Rail Project. The ₹1,007 crore project is part of package BH-05 and focuses on the city’s metro rail infrastructure. The company has received a formal Letter of Acceptance (LOA) from Madhya Pradesh Metro Rail Company Limited, confirming the allotment of the project.

HBL Power Systems: HBL Power Systems has bagged a significant order worth ₹1,522.4 crore from Chittaranjan Locomotive Works. The contract includes the supply, installation and commissioning of Train Collision Avoidance Systems (TCAS) for 2,200 locomotives. The project is expected to be completed within 12 months of the issuance of the purchase order, underlining the company's expertise in safety and signaling solutions.

Comments

  1. AFCONS Infrastructure: AFCONS Infrastructure has been awarded a significant contract by Madhya Pradesh Metro Rail Corporation for the Bhopal Metro Rail Project.

    ReplyDelete

Post a Comment